C07C 317/36
With the nitrogen atoms of the amino groups bound to hydrogen atoms
Official title: with the nitrogen atoms of the amino groups bound to hydrogen atoms or to carbon atoms
C07C317/36 (With the nitrogen atoms of the amino groups bound to hydrogen atoms) appears on 192 US grants and 172 published applications in this corpus.
Search patents in C07C- Granted patents
- 192
- Published applications
- 172
- Assignees
- 120
- Inventors
- 566
- Latest grant
- 2 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 3 | 0 |
| 1992 | 4 | 0 |
| 1993 | 4 | 0 |
| 1994 | 6 | 0 |
| 1995 | 4 | 0 |
| 1996 | 2 | 0 |
| 1997 | 7 | 0 |
| 1998 | 4 | 0 |
| 1999 | 7 | 0 |
| 2000 | 0 | 0 |
| 2001 | 2 | 1 |
| 2002 | 13 | 9 |
| 2003 | 4 | 17 |
| 2004 | 15 | 8 |
| 2005 | 5 | 4 |
| 2006 | 6 | 10 |
| 2007 | 1 | 7 |
| 2008 | 2 | 3 |
| 2009 | 6 | 5 |
| 2010 | 5 | 6 |
| 2011 | 4 | 3 |
| 2012 | 5 | 6 |
| 2013 | 3 | 8 |
| 2014 | 8 | 6 |
| 2015 | 8 | 5 |
| 2016 | 5 | 6 |
| 2017 | 4 | 6 |
| 2018 | 9 | 15 |
| 2019 | 8 | 4 |
| 2020 | 5 | 9 |
| 2021 | 6 | 3 |
| 2022 | 3 | 8 |
| 2023 | 6 | 9 |
| 2024 | 7 | 8 |
| 2025 | 5 | 3 |
| 2026 | 3 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- USP30 inhibitors and uses thereof2 Jun 2026US 12,643,852 B2Vincere Biosciences, Inc.
- Antibacterial compounds2 Jun 2026US 12,643,875 B2The Penn State Research Foundation
- Compound as a UBR box domain ligand24 Feb 2026US 12,559,455 B2Autotac Inc.
- Compound as a UBR box domain ligand30 Dec 2025US 12,509,420 B2Autotac Inc.
- Chalcone-based chemotherapeutic compound for triple negative breast cancer30 Sep 2025US 12,428,405 B2Qatar University
- Usp30 inhibitors and uses thereof1 Oct 2026US 2026/0297026 A1Vincere Biosciences, Inc.
- Antibacterial compounds17 Sep 2026US 2026/0274816 A1The Penn State Research Foundation
- Chalcone-based chemotherapeutic compounds and treatments for cancer23 Jul 2026US 2026/0209209 A1Qatar University
- Aminotetraline activators of serotonin receptors11 Sep 2025US 2025/0282708 A1Atai Therapeutics, Inc.
- Tetralin and tetrahydroquinoline compounds as inhibitors of hif-2alpha3 Jul 2025US 2025/0214930 A1Arcus Biosciences, Inc.
Most cited
By later US patents
- Prostaglandin synthase inhibitors169US 5,593,994 AThe DuPont Merck Pharmaceutical Company · 1997
- Tetraaryl benzidines128US 5,639,914 AHodogaya Chemical Co., Ltd. · 1997
- Amine compound and electro-luminescence device comprising same122US 5,707,747 AHodogaya Chemical Co., Ltd. · 1998
- Aryl aniline β2 adrenergic receptor agonists62US 6,670,376 B1Theravance, Inc. · 2003
- Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors54US 6,207,669 B1Glaxo Wellcome Inc. · 2001